Journal of Skin Cancer

Melanoma: From Research to Treatment


Publishing date
15 Sep 2011
Status
Published
Submission deadline
15 Mar 2011

1Department of Medical Oncology and Innovative Therapy, National Cancer Institute, “Fondazione G. Pascale”, Napoli, Italy

2Melanoma and Skin Cancer Program, Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

3Department of Transfusion Medicine, Clinical Center; Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, MA, USA

4Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council (CNR), Sassari, Italy


Melanoma: From Research to Treatment

Description

Melanoma has shown a rapid increase in its incidence rate over the past two decades, especially in early-stage disease. Characterization of the molecular mechanisms involved in the development and progression of melanoma could be helpful to identify the molecular profiles underlying aggressiveness, clinical behavior, and response to therapy as well as to better classify the subsets of melanoma patients with different prognosis and/or clinical outcomes. Treatment for both early and advanced melanomas has been changed a little since the introduction of interferon and IL-2 in the early 1990s. Anyway, recent data from trials testing targeted agents or immune modulators suggest the promise of new strategies to treat patients with advanced melanoma.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the molecular basis of melanoma progression and to improve prevention, diagnosis, surgical treatment, immunotherapy, and new possible strategies.

We are particularly interested in articles describing the new pathway involved in melanoma genesis, new diagnostic tools, improvements in surgical treatment, biomarkers, new molecular immunotherapeutic approaches, and new potential targets agents for antitumor and immunomodulatory therapy. Potential topics include, but are not limited to:

  • Recent developments in molecular mechanism of melanoma genesis
  • Advances in genetics of melanoma
  • New prevention strategies and new approaches for early diagnosis
  • Advances in surgical procedures for melanoma treatment
  • Advances in biomarkers for the prognosis and predictive for the response to treatment
  • Targeted therapies
  • New strategies for the treatment of advanced diseases
  • Novel physiopathological models to evaluate melanoma treatment
  • Synergy and addition of the various signaling pathways

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jsc/guidelines.html. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2011
  • - Article ID 710697
  • - Editorial

Melanoma: From Research to Treatment

Paolo A. Ascierto | John M. Kirkwood | ... | Giuseppe Palmieri
  • Special Issue
  • - Volume 2011
  • - Article ID 845863
  • - Review Article

Management of Melanoma Brain Metastases in the Era of Targeted Therapy

Daniela Gonsalves Shapiro | Wolfram E. Samlowski
  • Special Issue
  • - Volume 2011
  • - Article ID 521947
  • - Review Article

Prognostic Parameters for the Primary Care of Melanoma Patients: What Is Really Risky in Melanoma?

Daniela Göppner | Martin Leverkus
  • Special Issue
  • - Volume 2011
  • - Article ID 273280
  • - Review Article

The Contribution of Electron Paramagnetic Resonance to Melanoma Research

Quentin Godechal | Bernard Gallez
  • Special Issue
  • - Volume 2011
  • - Article ID 106573
  • - Review Article

Treatment of Locally Advanced Melanoma by Isolated Limb Infusion with Cytotoxic Drugs

Hidde M. Kroon
  • Special Issue
  • - Volume 2011
  • - Article ID 573974
  • - Review Article

Uveal Melanoma

Vasilios P. Papastefanou | Victoria M. L. Cohen
  • Special Issue
  • - Volume 2011
  • - Article ID 574695
  • - Research Article

Characterization of Ex Vivo Expanded Tumor Infiltrating Lymphocytes from Patients with Malignant Melanoma for Clinical Application

Niels Junker | Per thor Straten | ... | Inge Marie Svane
  • Special Issue
  • - Volume 2011
  • - Article ID 598571
  • - Research Article

Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma

Joanne M. Jeter | Joseph D. Bonner | ... | Stephen B. Gruber
Journal of Skin Cancer
 Journal metrics
Acceptance rate29%
Submission to final decision34 days
Acceptance to publication25 days
CiteScore2.100
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.